Zoetis Inc.
ZTSNYSEHealthcare● Active
$78.81
$-0.63(-0.79%)
Market Cap$33.0B
P/E Ratio—
52W High$171.52
52W Low$72.38
Zoetis Inc.（ZTS）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ZTS · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $2.67B | $2.50B | $2.34B | $2.11B | $2.03B |
| Depreciation & Amort. | $0.49B | $0.50B | $0.49B | $0.47B | $0.45B |
| Stock-Based Comp. | $0.08B | $0.07B | $0.06B | $0.06B | $0.06B |
| Change in Working Capital | ($0.41B) | $0.08B | ($0.51B) | ($0.70B) | ($0.34B) |
| Net Cash from Operations | $2.90B | $2.95B | $2.35B | $1.91B | $2.21B |
| Investing Activities | |||||
| Capital Expenditure | ($0.62B) | ($0.66B) | ($0.73B) | ($0.59B) | ($0.48B) |
| Purchases of Investments | ($0.01B) | ($0.01B) | ($0.00B) | ($0.01B) | ($0.01B) |
| Sales of Investments | $0.00B | $0.00B | $0.01B | $0.02B | $0.04B |
| Net Cash from Investing | ($0.75B) | ($0.32B) | ($0.78B) | ($0.88B) | ($0.46B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($3.23B) | ($1.86B) | ($1.09B) | ($1.59B) | ($0.74B) |
| Dividends Paid | ($0.89B) | ($0.79B) | ($0.69B) | ($0.61B) | ($0.47B) |
| Debt Issued / Repaid | $2.27B | ($0.00B) | ($1.35B) | $1.35B | ($0.60B) |
| Net Cash from Financing | ($1.87B) | ($2.66B) | ($3.11B) | ($0.90B) | ($1.86B) |
| Free Cash Flow | |||||
| Free Cash Flow | $2.28B | $2.30B | $1.62B | $1.33B | $1.74B |
| FCF Margin %(computed) | 24.12% | 24.83% | 18.97% | 16.41% | 22.33% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Zoetis Inc.
关于Zoetis Inc.（ZTS）现金流量表
Zoetis Inc. 2025财年经营活动现金流$2.90B，自由现金流$2.28B（FCF利润率24.12%），资本支出($0.62B)。
常见问题
ZTS · 4 问Zoetis Inc. 2025财年自由现金流$2.28B，同比down0.7%。
ZTS free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10